Retatrutide is a newly developed drug that acts as a strong GLP-1 receptor activator. This revolutionary treatment holds significant potential for controlling type 2 diabetes. By replicating the actions of natural GLP-1, Retatrutide boosts insulin secretion and suppresses glucagon release, leading to improved glycemic control. Clinical trials have